{"nct_id":"NCT01239797","title":"Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma","status":"COMPLETED","status_verified_date":"2022-05","start_date":"2011-06-20","start_date_type":"ACTUAL","primary_completion_date":"2014-09-02","primary_completion_date_type":"ACTUAL","completion_date":"2021-04-21","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["BMY"]}